These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 29034584)

  • 1. Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.
    Ratay ML; Bellotti E; Gottardi R; Little SR
    Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 29034584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of complement system in ocular diseases including uveitis and macular degeneration.
    Jha P; Bora PS; Bora NS
    Mol Immunol; 2007 Sep; 44(16):3901-8. PubMed ID: 17768108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of ocular inflammation and innate immune response].
    Sonoda KH
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):279-97; discussion 298. PubMed ID: 18411715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune mechanisms in inflammatory and degenerative eye disease.
    Perez VL; Caspi RR
    Trends Immunol; 2015 Jun; 36(6):354-63. PubMed ID: 25981967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of chemokines in ocular diseases. Part II. Participation of chemokines in ocular diseases].
    Malesiński R; Mrugacz M; Bakunowicz-Łazarczyk A
    Klin Oczna; 2007; 109(7-9):345-8. PubMed ID: 18260295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The link between morphology and complement in ocular disease.
    Mohlin C; Sandholm K; Ekdahl KN; Nilsson B
    Mol Immunol; 2017 Sep; 89():84-99. PubMed ID: 28622910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics, microbiota, and intraocular inflammation: New paradigms of immune regulation in the eye.
    Wen X; Hu X; Miao L; Ge X; Deng Y; Bible PW; Wei L
    Prog Retin Eye Res; 2018 May; 64():84-95. PubMed ID: 29357307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.
    Agrahari V; Aulgur Z; Thukral S; Dhall N; Conley R; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):92-106. PubMed ID: 28901856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Relevant Models for Ocular Inflammatory Diseases.
    Gilger BC
    ILAR J; 2018 Dec; 59(3):352-362. PubMed ID: 29474707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the intestinal microbiome in ocular inflammatory disease.
    Lin P
    Curr Opin Ophthalmol; 2018 May; 29(3):261-266. PubMed ID: 29538183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doyne lecture 2016: intraocular health and the many faces of inflammation.
    Dick AD
    Eye (Lond); 2017 Jan; 31(1):87-96. PubMed ID: 27636226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?
    Ooi KG; Galatowicz G; Calder VL; Lightman SL
    Clin Med Res; 2006 Dec; 4(4):294-309. PubMed ID: 17210978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pediatric patients with noninfectious idiopathic uveitis and noninfectious uveitis associated with an underlying systemic disease: from a referral center in Turkey.
    Ozdel S; Baglan E; Gungor T; Yazılıtas F; Cakıcı EK; Ozdal PC; Bulbul M
    Postgrad Med; 2021 May; 133(4):444-448. PubMed ID: 33691583
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intraocular inflammation and homeostasis of the eye].
    Mochizuki M
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninfectious immune-mediated uveitis and ocular inflammation.
    Pan J; Kapur M; McCallum R
    Curr Allergy Asthma Rep; 2014 Jan; 14(1):409. PubMed ID: 24338488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases.
    Fabiani C; Sota J; Tosi GM; Franceschini R; Frediani B; Galeazzi M; Rigante D; Cantarini L
    Clin Rheumatol; 2017 Oct; 36(10):2307-2318. PubMed ID: 28032234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Chemokines in Shaping Macrophage Activity in AMD.
    Rutar M; Provis JM
    Adv Exp Med Biol; 2016; 854():11-6. PubMed ID: 26427387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Challenges and Promise of Complement Therapeutics for Ocular Diseases.
    Park DH; Connor KM; Lambris JD
    Front Immunol; 2019; 10():1007. PubMed ID: 31156618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management.
    Foster CS; Kothari S; Anesi SD; Vitale AT; Chu D; Metzinger JL; Cerón O
    Surv Ophthalmol; 2016; 61(1):1-17. PubMed ID: 26164736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation.
    Foxman EF; Zhang M; Hurst SD; Muchamuel T; Shen D; Wawrousek EF; Chan CC; Gery I
    J Immunol; 2002 Mar; 168(5):2483-92. PubMed ID: 11859142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.